UPenn HIV Grand Rounds - Home Page


Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania, The Penn Cener for AIDS Research and ViralEd, Inc.

Live Series Schedule

About the Program

Program Overview

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access. 

Back to Top

Target Audience

This program has been designed for Family Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease

Back to Top

Commercial Support Acknowledgement

HIV Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs,  ViiV Healthcare, Janssen Therapeutics and Merck Sharp and Dohme Corp.

Back to Top

Learning Objectives

After completing this activity, participants should be better able to:

  • Apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients into care
  • Individualize ARV therapy for the treatment-naïve and treatment-experienced patients
  • Manage the aging patient with HIV infection, including issues associated with cardiovascular and bone disease
Back to Top

Course Director

Ian Frank. MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Next Session and Participation Information

Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand

  • Delivered via webinar directly to you  and/or your clinic
  • You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
  • Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device

If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.

Back to Top

Live Session Topics and Speakers

January 9, 2020

The use of mHealth to address the HIV continuum with sexual and gender minorities

Keith Horvath, PhD

Click HERE view On-Demand

January 16, 2020

Bias and HIV Health Care Outcomes: Historical Trauma's Impact on HIV Care

Michele Andrasik, PhD

Click HERE to Register

October 3, 2019

Highlights from the 2019 IAS Meeting and Other Things You May Have Missed This Summer

Ian Frank, MD

Click HERE to view On-Demand

October 10, 2019

Tissues Issues:  Mucosal Immunity in Chronic HIV Infection

Barbara Shacklett, PhD

Click HERE to View On-Demand

October 17, 2019

MIneralocorticoid Receptor Antagonism for CardiovascuLar HEalth in HIV: Should we believe in MIRACLES's?

Suman Srinivasa, MD, MS

Click HERE to View On-Demand

October 24, 2019

Real Cases from the University of Pennsylvania

David Kaplan, MD

Click HERE to View On-Demand

October 31, 2019

If we build will they come?: Approaches to Engage Priority Youth Populations

Renata Arrington-Sanders, MD

Click HERE to View On-Demand

November 7, 2019

mRNA vaccines for HIV infection

Drew Weissman, MD

Click HERE to View On-Demand

November 14, 2019

Topic: The Future of ART

Roy Gulick, MD

Click HERE to View On-Demand

November 21, 2019

AASLD 2019 Update (Hep GR Replay from 11/20/19)

Mark Sulkowski, MD

Click HERE to View On-Demand

December 5, 2019

Topic: Immune Activation in Treated HIV: The Role of Asymptomatic CMV Replication

Peter Hunt, MD

Click HERE to View On-Demand



Back to Top

Hardware/Software Notice

You will need Internet to participate in this activity.


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE), Mila Kostic, CHCP, FACEHP, Director of CME and Co-Director of IPCE Penn Medicine, Zalman Agus, MD, Senior Peer Reviewer and Patricia A. Smith, DNP, RN-BC, Penn IPCE Lead Nurse Planner have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Members:

  • ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
  • UPenn CME: Mila Kostic, CHCP, FACEHP

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

Ian Frank, MD (Program Chair)

  • Advisor or Review Panel Member:Gilead; GlaxoSmithKline
  • Grant/Research Support Recipient: Johnson & Johnson
Back to Top

Discussion of Investigational and/or Off-label Use of Commercial Products and Devices

The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Back to Top


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.


    UPenn CME - 2019          VE Logo 2019           CFAR 2019




Back to Top


ViralEd, LLC